Effects of the combination of TRC105 and bevacizumab on endothelial cell biology

Overview of attention for article published in Investigational New Drugs, July 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

patent: 5 patents

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 44 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Use of anti-endoglin antibodies for treating ocular fibrosis

Grant US-10336831-B2

United States of America

Antibody formulations and uses thereof

Grant US-10195281-B2

United States of America

Anti-endoglin antibodies and uses thereof

Grant US-10155820-B2

United States of America

Anti-endoglin antibodies and uses thereof

Grant US-9926375-B2

United States of America

Endoglin antibodies

Grant US-9518122-B2

United States of America